Daniel Weintraub
University of Pennsylvania
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Daniel Weintraub.
Journal of the American Geriatrics Society | 2004
Daniel Weintraub; Paul J. Moberg; John E. Duda; Ira R. Katz; Matthew B. Stern
Objectives: To examine the effect of depression and other nonmotor symptoms on functional ability in Parkinsons disease (PD).
Journal of Geriatric Psychiatry and Neurology | 2003
Daniel Weintraub; Paul J. Moberg; John E. Duda; Ira R. Katz; Matthew B. Stern
Depression in Parkinsons disease (PD) is common, but little is known about its recognition and treatment. The authors report the antidepressant experience (N = 100) and outcome of depression assessment (n = 77) of a convenience sample of patients at a PD center. Subjects were assessed with a psychiatric and neurological battery, and information was gathered on depression treatment. One third (34%) of subjects met criteria for a depressive disorder, and two thirds (65%) of them were not currently receiving antidepressant treatment. Approximately one quarter (23%) of subjects were taking an antidepressant, but almost half (47%) of them still met criteria for a depressive disorder. Few antidepressant users with persistent depression had received either antidepressant treatment at dosages within the highest recommended range (11%) or more than 1 antidepressant trial (33%). Most depressed patients are untreated, and half of antidepressant users remain depressed, suggesting that even when delivered, treatment is often inadequate or ineffective. (J Geriatr Psychiatry Neurol 2003; 16:178-183).
Assessment | 2004
William C. Culbertson; Paul J. Moberg; John E. Duda; Matthew B. Stern; Daniel Weintraub
The aim of the study was to investigate the utility of the Tower of London-Drexel (TOL DX ) in assessing the executive deficits associated with Parkinson’s disease (PD). We sought to determine whether the TOL DX would differentiate between (a) patients with PD and healthy control participants (HCP), (b) demented and nondemented patients, and (c) depressed and nondepressed patients. A new TOL DX score, stimulus bound, was introduced to assess utilization behaviors. Furthermore, the convergent and divergent validity of the TOL DX was examined. The TOL DX total move, rule and time violation, and stimulus-bound scores of patients with PD significantly differed from the HCP. Demented and nondemented patients also differed significantly in their TO DX performance, with the stimulus-bound score being the most significantly differentiating score. However, the depressed and nondepressed patients did not differ in their TOL DX performance. Support was found for the convergent and divergent validity of the TOL DX. The clinical and theoretical implications of the findings are discussed.
The Journal of Clinical Psychiatry | 2018
Maria Rita Lo Monaco; Martina Petracca; Daniel Weintraub; Domenico Fusco; Rosa Liperoti; Giuseppe Zuccalà; Domenico La Carpia; Davide L. Vetrano; Danilo Genovese; Maria Stella Pisciotta; Vincenzo Brandi; Luca Padua; Isabella Imbimbo; Diego Ricciardi; Roberto Bernabei; Maria Caterina Silveri; Alice Laudisio; Anna Rita Bentivoglio
BACKGROUND Impulse-control disorders (ICDs) are frequently described in patients with Parkinsons disease (PD), particularly among those treated with dopaminergic medications, but data on the prevalence of ICDs in elderly populations are lacking. OBJECTIVE The aim of this study was to estimate the prevalence of ICDs by using an Italian validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinsons Disease (QUIP) and to identify associated sociodemographic and clinical factors in a sample of elderly PD patients and in a control group of similarly aged healthy volunteers. METHODS Using the United Kingdom Parkinsons Disease Society Brain Bank diagnostic criteria, we included 115 consecutive PD and 105 healthy controls. They were recruited from June 2014 to December 2015. All participants completed the self-administered QUIP-Anytime for assessment of ICDs occurring any time during the course of PD. RESULTS Mean ± SD age was 75.7 ± 7.0 years in the PD patients and 76.1 ± 7.0 years in the control group. The mean disease duration was 6.8 years (range, 1-26 years). Among the PD patients, 44.7% (n = 51) had at least 1 ICD or related disorder compared to 25.2% (n = 26) in the control group (between-group difference: P = .003). Hypersexuality and compulsive shopping were significantly more common in the PD group than in the control group (P < .05). The prevalence of other compulsive behaviors was 42.5% in the PD group and 38.9% in the control group (P = NS). The Italian version of the QUIP-Anytime showed high test-retest reliability (κ > 0.70 for all items). CONCLUSIONS Our data confirm a high prevalence of ICD symptoms in elderly PD patients, approximately twice that seen in the general population.
The Journal of Nuclear Medicine | 2005
Daniel Weintraub; Andrew B. Newberg; Mark S. Cary; Andrew Siderowf; Paul J. Moberg; Galit Kleiner-Fisman; John E. Duda; Matthew B. Stern; David Mozley; Ira R. Katz
The Journal of Clinical Psychiatry | 2003
David W. Oslin; Thomas R. Ten Have; Joel E. Streim; Catherine J. Datto; Daniel Weintraub; Suzanne DiFilippo; Ira R. Katz
Cognitive and Behavioral Neurology | 2004
Daniel Weintraub; Paul J. Moberg; William C. Culbertson; John E. Duda; Matthew B. Stern
Current Neurology and Neuroscience Reports | 2006
Daniel Weintraub; Marc N. Potenza
Current Neurology and Neuroscience Reports | 2006
Daniel Weintraub; Marc N. Potenza
Psychiatric Annals | 2004
Daniel Weintraub